CORRELATION OF STORAGE SYMPTOMS OR OVERACTIVE BLADDER SYMPTOMS POST TRANSURETHRAL RESECTION OF THE PROSTATE WITH THE DURATION OF CATHETER USE IN A PATIENT WITH URINARY RETENTION DUE TO BENIGN PROSTATE HYPERPLASIA
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
Abstract
Objective: Find out the correlation of catheter use duration with the incidence of overactive bladder symptoms (OABS) post Transurethral Resection of The Prostate (TURP) in patients with urinary retention due to Benign Prostate Hyperplasia (BPH). Material & Methods: An observational analytical research correlation with a cohort approach was carried out on 29 patients with urinary retention due to BPH post TURP in five hospitals in Padang from January 2019 to August 2019. Data collected included the characteristics and duration of catheter use, which were obtained through interviews using questionnaires, while those of OABS were obtained based on the total score by using the overactive bladder symptoms score (OABSS) standard questionnaire. Results: The average duration of catheter use was 14.9 ± 8.0 days, and the average total OABSS score was 4.7 ± 2.5. Bivariate analysis results showed a positive correlation with a weak strength between the duration of catheter use and the total OABSS score (Pearson’s correlation, r = 0.396, p = 0.033). Conclusion: It is necessary to shorten the duration of catheter use to decrease the incidence and severity of OABS in patients with urinary retention due to BPH post TURP. Keywords: Benign Prostate Hyperplasia, duration of catheter use, overactive bladder, urinary retention.
##plugins.themes.bootstrap3.article.details##
Benign Prostate Hyperplasia, duration of catheter use, overactive bladder, urinary retention.
Welliver C, Helo S, McVary KT. Technique considerations and complication management in transurethral resection of the prostate and photoselective vaporization of the prostate. Transl Androl Urol. 2017; 6(4): 695–703.
Gravas S, Bachmann A, Descazeaud A, Drake M, Gratzke C, Madersbacher S, et al. Guidelines on the Management of Male Lower Urinary Tract Symptoms Benign Prostatic Obstruction ( BPO ). Eur Assoc Urol. 2012; 64: 118–40.
Fitzpatrick JM, Desgrandchamps F, Adjali K, Gomez GL, Hong SJ, Khalid ES, et al. Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia. BJU Int. 2012; 109(1): 88-95.
Anutrakulchai S. Residual LUTS after Transurethral Resection of Prostate ( TURP ): The Urodynamic Studies in Chiangmai University. Thai J Surg. 2005; 26: 82–7.
Zhang Z, Cao Z, Xu C, Wang H, Zhang C, Pan A, et al. Solifenacin is able to improve the irritative symptoms after transurethral resection of bladder tumors. Urology 2014; 84: 117–121.
Banakhar MA, Al-Shaiji TF, Hassouna MM. Pathophysiology of overactive bladder. Int Urogynecol J. 2012; 23(8): 975–82.
Hu B, Li C, Pan M, Zhong M, Cao Y, Zhang N, et al. Strategies for the prevention of catheter-related bladder discomfort. Medicine(Baltimore). 2016; 95(37): e4859.
Yadav G, Prashanth M, Singh RB, Jain G, Singh Y, Meena RK. Incidence and severity of catheter related bladder discomfort by using different inhalational anesthetic agents and comparing it with propofol. Anaesth Pain & Intensive Care 2015; 19(4): 452-456
Andersson KE. Detrusor myocyte activity and afferent signaling. Neurourol Urodyn 2010; 29: 97–106
Bai Y, Wang X, Li X, Pu C, Yuan H, Tang Y, et al. Management of catheter-related bladder discomfort in patients who underwent elective surgery. J Endourol. 2015; 29: 640–649.
Maro S, Zarattin D, Baron T, Bourez S, de la Taille A, Salomon L. Catheter-related bladder discomfort after urological surgery: Importance of the type of surgery and efficiency of treatment by clonazepam. Prog Urol 2014; 24: 628–633.
Li C, Liu Z, Yang F. Predictors of catheter-related bladder discomfort after urological surgery. J Huazhong Univ Sci Technol - Med Sci. 2014; 34(4): 559–62.
Manley K V., Hubbard R, Swallow D, Finch W, Wood SJ, Biers SM. Risk factors for development of primary bladder squamous cell carcinoma. Ann R Coll Surg Engl. 2017; 99(2): 155–60.
Birder L, Andersson K-E. Urothelial Signaling. Physiological Reviews. 2013; 93(2): 653-680.
Ugare UG, Bassey IA, Udosen EJ, Essiet A, Bassey OO. Management of lower urinary retention in a limited resource setting. Ethiop J Health Sci. 2014; 24(4): 329–336.
Desgradchamps F, Dela Taille A, Doublet JD. The management of acute urinary retention in France; a cross sectional survey in 2,618 men with benign prostatic hyperplasia. BJU. 2006; 97: 727–733.
De Nunzio C, Franco G, Rocchegiani A, Iori F, Leonardo C, Laurenti C. The evolution of detrusor overactivity after watchful waiting, medical therapy and surgery in patients with bladder outlet obstruction. J Urol. 2003; 169: 535–9
Gacci M, Sebastianelli A, Spatafora P, Corona G, Serni S, Ridder DD, et al. Best practice in the management of storage symptoms in male lower urinary tract symptoms: a review of the evidence base. Ther Adv Urol. 2017; 10(2): 79–92.
Merrill L, Gonzalez EJ, Girard BM, Vizzard MA. System in the Bladder. 2017; 13(4): 193–204.
Binhas M, Motamed C, Hawajri N, Yiou R, Marty J. Facteurs prédictifs d’inconfort de sonde vésicale en salle de réveil. Ann Fr Anesth Reanim. Elsevier Masson SAS; 2011; 30(2): 122–5.
Birder L, WC de G. Mechanism of Disease: involvement of the urothelium in bladder dysfunction. Nat Clin Pr Urol. 2011; 4(1): 46–54.
Fry CH, Vahabi B. The Role of the Mucosa in Normal and Abnormal Bladder Function. Basic Clin Pharmacol Toxicol. 2016; 119(3): 57–62.
Ramakrishnan K, Mold J. Urinary Catheters: A Review. Internet J Fam Pract. 2012; 3(2): 1–12.
Nazarko L. Catheter care in the community. Nurse Stand. 2008; 14: 46–51.